Predicting treatment outcomes using 18F|FDG PET biomarkers in ...

Predicting treatment outcomes using 18F-FDG PET biomarkers in ...

PET/CT variables and NLR were useful biomarkers for predicting outcomes of patients with NSCLC receiving pembrolizumab and chemotherapy as a first-line ...

Predicting treatment outcomes using 18F-FDG PET biomarkers in ...

Among various PD-1 inhibitors, pembrolizumab and nivolumab have been shown to significantly prolong the survival in patients with advanced NSCLC. ... Importantly, ...

Predicting treatment outcomes using 18F-FDG PET biomarkers in ...

has become the mainstay treatment strategy for. Predicting treatment outcomes using. 18F-FDG PET biomarkers in patients with non-small-cell lung cancer.

Predicting treatment outcomes using 18F-FDG PET biomarkers in ...

Results: During the median follow-up period of 16.7 months (95% confidence interval: 15.7–17.7 months), 43 (82.7%) and 31 (59.6%) patients ...

Predicting treatment outcomes using >18>F-FDG PET biomarkers in ...

Background: Predictive markers for treatment response and survival outcome have not been identified in patients with advanced non-small-cell lung cancer (NSCLC) ...

Predicting treatment outcomes using 18 F-FDG PET biomarkers in ...

Conclusion PET/CT variables and NLR were useful biomarkers for predicting outcomes of patients with NSCLC receiving pembrolizumab and ...

Prediction of Treatment Outcome and Survival Using 18F-FDG PET ...

Conclusions: Radiomic features extracted from baseline FDG PET/CT images were mostly unsuccessful at predicting OS, PFS, or DICB treatment ...

FDG PET biomarkers for prediction of survival in metastatic ... - Nature

Immunotherapy using immune checkpoint inhibitors (ICI) targeting programmed cell death 1 receptor (PD-1) is now a well-established treatment for ...

Use of 18F-FDG PET/CT as a Predictive Biomarker of Outcome in ...

The intensity of FDG uptake is emerging as a valuable predictive factor regarding treatment outcome [5, 11, 19, 20]. FDG PET has been shown to accurately ...

Can Biomarkers Predict Treatment Outcomes in Hodgkin Lymphoma ...

For patients with Hodgkin lymphoma, early or interim fluorodeoxyglucose (FDG)–PET scanning after two cycles of chemotherapy (PET-2) has been ...

Prognostic value of 18F-FDG PET/CT in patients with ... - Frontiers

... therapy of non-small cell lung cancer: Baseline metabolic biomarkers predict outcomes. ... Predicting treatment outcomes using (18)F-FDG ...

Pretreatment 18-FDG-PET/CT parameters can serve as prognostic ...

Original Article. Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation- ...

An artificial intelligence method using FDG PET to predict treatment ...

The aim of this study was to investigate the feasibility of a CNN for the prediction of 2-year time-to-progression (TTP) in DLBCL patients using ...

Evaluation in Independent Cohorts of Non–Small Cell Lung Cancer ...

PERTINENT FINDINGS: NHOC and NHOP biomarkers are robust to postfiltering of PET images and voxel size. They do not substantially correlate with ...

18F-FDG PET can effectively rule out conversion to dementia and ...

A normal brain 18 F-FDG PET scan can help rule out the risk of dementia conversion and the presence of cerebrospinal fluid (CSF) biomarker of neurodegeneration ...

Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for ...

Background: [18F]FDG PET/CT is used for staging and could also provide information associated with clinical outcomes. The objective of this ...

PSMA and FDG-PET as predictive and prognostic biomarkers in ...

Previously, results from the TheraP trial showed that treatment with lutetium-177 [177Lu]Lu-PSMA-617 improved frequency of prostate-specific antigen (PSA) ...

Imaging Biomarkers to Predict Outcomes in Patients With Large B ...

Day 28 partial response by PET/CT following chimeric antigen receptor T-cell therapy creates clinical uncertainty for both clinicians and ...

Early prediction of treatment outcome for lenvatinib using 18 F-FDG ...

We attempted to confirm that FDG PET/CT can predict treatment outcome 1 week after the initiation of lenvatinib treatment and to our knowledge, ...

18F-FDG PET/CT Imaging Biomarkers for CAR-T Cell Therapy ...

Additionally, we present, for the first time, the relevance of granular radiomic features in assessing the probability of treatment success. If ...